Clinical Trial Update: A Prospective Multicenter Trial Evaluating Helios Biodegradable Polymer SES Safety and Effectiveness in CAD Treatment [Phase 4]

View source ↗

Summary

A Phase 4 multicenter trial assessing the safety and effectiveness of the Helios Biodegradable Polymer SES in treating coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Helios Biodegradable Polymer SES

Snippet

Sponsor: Kinhely Bio-tech Co., Ltd. | Conditions: Coronary Artery Disease | Phase 4 | Status: UNKNOWN